Efficacy of trelagliptin for glucose fluctuation, oxidative stress and inflammation in patients with type 2 diabetes mellitus. - Efficacy of trelagliptin for glucose fluctuation, oxidative stress and inflammation in patients with type 2 diabetes mellitus.

Ise Red Cross Hospital Department of Metabolic Diseases0 个研究点目标入组 20 人开始时间: 2015年7月17日最近更新: 2023年10月17日

试验速览

暂无简介。

•1) Type 1 diabetes 2) Had ketosis or coma within 6 month 3) Secondary diabetes 4) Patients receiving insulin or GLP-1 analogue therapy 5) Poor-controlled diabetes (HbA1c>10.0 % or fasting blood glucose levels>250mg/dl) 6) History of stroke, acute coronary syndrome or any cardiovascular diseases needed for inpatient-treatments within 6 months 7) Either level of aspartate aminotransaminase or alanine aminotransferase exceed three-fold of the normal limits 8) Renal insufficiency: serum creatinine>1.5 or Ccr<50ml/min 9) Malignancies or other diseases with poor prognosis 10) Pregnant 11) Subjects whose doctor in charge do not agree to join the trial

发起方

Ise Red Cross Hospital Department of Metabolic Diseases